Selected articles in the news include:

• FDA Approves Zytiga (abiraterone acetate) for Prostate Cancer. Howard Scher, MD, of Memorial Sloan-Kettering Cancer Center is quoted in article.
• Cancer research, treatment move toward individualized care – Genomics plays an increasingly critical role in the clinic. Martin R. Weiser, MD, associate attending surgeon at Memorial Sloan-Kettering Cancer Center is quoted in article.
• Study Supports Paradigm Shift in Invasive Bladder Cancer.  Mentioned in article was Dean F. Bajorin, MD, and Harry W. Herr, MD, from Memorial Sloan-Kettering Cancer Center.